Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Plans for future expansion at its sites in Portugal, Ireland and New Jersey
March 19, 2018
By: Kristin Brooks
Managing Editor, Contract Pharma
Hovione has recently expanded capacity and plans for future expansion at its sites in Portugal, Ireland and New Jersey. The company will increase capacity in existing technologies, such as spray drying, and grow in new areas to support clients demand. The capacity expansion began in 2016 and will continue over the next five years. In the first two years, Hovione relocated its development services to a new center in Lisbon with 7,000 m2, and is fully equipped to handle potent compounds. The new building hosts 200 scientists from the chemistry, particle engineering, formulation and analytical development areas. The Loures site also expanded its drug substance reaction vessel capacity with a small-scale production area and a new pilot plant, totaling additional 30 m3 of capacity. In addition, one pilot and two large scale spray dryers were installed at the site, which is now equipped with oral dosage form and inhalation manufacturing capabilities. Hovione doubled the size of its development and manufacturing operations in NJ, adding a range of capabilities, from chemical and analytical development to spray drying and formulation. The site now hosts 14 m3 of reaction vessel capacity with four independent trains, a pilot and a large-scale spray dryer and a continuous tableting unit. In the Cork site in Ireland, Hovione is reinstating and renewing a production building with 157m3 of chemical synthesis capacity devoted to contract manufacturing. About half of this capacity will be ready for operation by May 2018. Over the next three years, Hovione will add to the Loures site a new chemical synthesis and spray dryer building for contract manufacturing, with a total of 4,200 m2 for 165m3 of reaction vessel capacity, two large spray drying units, new formulation facilities for bigger batch sizes, and a new building that will host additional 1200 m2 of analytical laboratories. These investments are supported by a 39% increase in staff in the last 2 years. “This addition in capacity expansion will secure our growth and ensure that we continue to provide a truly integrated full-service solution to our customers, as well as showing Hovione’s strategy and commitment to further strengthen its global market leadership in Spray Drying,” said Frédéric Kahn, vice president marketing and sales.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !